These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20615202)

  • 1. Miniaturized FISH for screening of onco-hematological malignancies.
    Zanardi A; Bandiera D; Bertolini F; Corsini CA; Gregato G; Milani P; Barborini E; Carbone R
    Biotechniques; 2010 Jul; 49(1):497-504. PubMed ID: 20615202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FISH panels for hematologic malignancies.
    Sreekantaiah C
    Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
    Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
    Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic quantification of gene amplification in clinical samples by IQ-FISH.
    Narath R; Lörch T; Rudas M; Ambros PF
    Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
    Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
    Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.
    McDevitt MA; Condon M; Stamberg J; Karp JE; McDiarmid M
    Mutat Res; 2007 Apr; 629(1):24-31. PubMed ID: 17276720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in fluorescence in situ hybridization (FISH) in hematology.
    Berger R
    Pathol Biol (Paris); 1995 Mar; 43(3):175-80. PubMed ID: 7675544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
    Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
    Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chromosome analysis and FISH method].
    Eguchi M; Tanaka K
    Rinsho Byori; 1996 Jun; 44(6):541-7. PubMed ID: 8752732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaphase FISH, microdissection, and multicolour FISH. Applications in haematology.
    Mecucci C; Falzetti D; La Starza R
    Haematologica; 1999 Jun; 84 Suppl EHA-4():98-101. PubMed ID: 10907483
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis of aneuploidy with fluorescence in situ hybridization (FISH); value in pregnancies with increased risk for chromosome aberrations].
    Ulmer R; Pfeiffer RA; Kollert A; Beinder E
    Z Geburtshilfe Neonatol; 2000; 204(1):1-7. PubMed ID: 10721179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
    Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
    Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization (FISH) in cytogenetics of leukemia.
    Michalová K
    Folia Biol (Praha); 1996; 42(6):311-4. PubMed ID: 9158941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
    Slovak ML; Tcheurekdjian L; Zhang FF; Murata-Collins JL
    Cancer Res; 2001 Feb; 61(3):831-6. PubMed ID: 11221864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
    Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
    Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
    Martín-Subero JI; Gesk S; Harder L; Grote W; Siebert R
    Anticancer Res; 2003; 23(2A):1139-48. PubMed ID: 12820362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of chromosome 13 deletions by fluorescent in situ hybridization.
    VanWier S; Fonseca R
    Methods Mol Med; 2005; 113():59-69. PubMed ID: 15968095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.